Perrigo Company plc Payments of Financing Costs
Perrigo Company plc (PRGO) reported Payments of Financing Costs of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2023-11-07
- Perrigo Company plc payments of financing costs for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Perrigo Company plc payments of financing costs for the quarter ending 2022-12-31 was $0.00.
- Perrigo Company plc payments of financing costs for the quarter ending 2022-10-01 was $1.40M.
- Perrigo Company plc payments of financing costs for the quarter ending 2021-12-31 was $0.00.
- Perrigo Company plc payments of financing costs for fiscal 2022 was $20.90M.
- Perrigo Company plc payments of financing costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Perrigo Company plc payments of financing costs for fiscal 2020 was $6.70M, a 570.00% increase from fiscal 2019.
- Perrigo Company plc payments of financing costs for fiscal 2019 was $1.00M, a 58.33% decline from fiscal 2018.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 3 month as first filed | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | |||
| 2023-07-01 | $0.00 10-Q · filed 2023-08-08 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.40M derived: sum of 2 quarters · filed 2023-11-07 | $20.90M 10-K · filed 2023-02-28 | ||
| 2022-10-01 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $20.90M 10-Q · filed 2023-11-07 | |||
| 2022-07-02 | $19.50M 10-Q · filed 2023-08-08 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 | ||
| 2021-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |||
| 2021-07-03 | $0.00 10-Q · filed 2022-08-09 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.70M derived: sum of 2 quarters · filed 2023-02-28 | $6.70M 10-K · filed 2023-02-28 | ||
| 2020-09-26 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $6.70M 10-Q · filed 2021-11-12 | |||
| 2020-06-27 | $5.00M 10-Q · filed 2021-08-11 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.00M derived: sum of 2 quarters · filed 2022-03-01 | $1.00M derived: sum of 3 quarters · filed 2022-03-01 | $1.00M 10-K · filed 2022-03-01 | |
| 2019-09-28 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.00M derived: sum of 2 quarters · filed 2020-11-05 | $1.00M 10-Q · filed 2020-11-05 | $1.00M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-30 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $2.40M 10-K · filed 2021-03-01 | |
| 2018-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $2.40M 10-Q · filed 2019-11-06 | $3.00M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $2.40M 10-Q · filed 2019-08-08 | $3.00M derived: sum of 3 quarters · filed 2020-02-27 | $3.20M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $2.40M 10-Q · filed 2019-05-09 | $3.00M derived: sum of 2 quarters · filed 2020-02-27 | $3.20M derived: sum of 3 quarters · filed 2020-02-27 | $6.80M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $800.00K derived: sum of 2 quarters · filed 2020-02-27 | $4.40M derived: sum of 3 quarters · filed 2020-02-27 | $4.80M 10-K · filed 2020-02-27 | |
| 2017-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.80M derived: sum of 2 quarters · filed 2018-11-08 | $4.20M 10-Q · filed 2018-11-08 | $4.20M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-07-01 | $3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $4.00M 10-Q · filed 2018-08-09 | $4.00M derived: sum of 3 quarters · filed 2019-02-27 | $4.40M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-04-01 | $400.00K 10-Q · filed 2018-05-08 | $400.00K derived: sum of 2 quarters · filed 2019-02-27 | $800.00K derived: sum of 3 quarters · filed 2019-02-27 | $1.70M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $400.00K derived: sum of 2 quarters · filed 2019-02-27 | $1.30M derived: sum of 3 quarters · filed 2019-02-27 | $2.80M 10-K · filed 2019-02-27 | |
| 2016-10-01 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.30M derived: sum of 2 quarters · filed 2017-11-09 | $2.80M 10-Q · filed 2017-11-09 | ||
| 2016-07-02 | $900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $2.40M 10-Q · filed 2017-08-10 | |||
| 2016-04-02 | $1.50M 10-Q · filed 2017-05-30 | ||||
| 2015-12-31 | $300.00K 10-K · filed 2018-03-01 | ||||
| 2015-09-26 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-05-23 | $0.00 derived: sum of 2 quarters · filed 2017-05-23 | $3.30M 10-Q/A · filed 2017-05-23 | $28.10M derived: sum of 4 quarters · filed 2017-05-23 | |
| 2015-06-27 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | $3.30M 10-Q/A · filed 2017-05-22 | $28.10M derived: sum of 3 quarters · filed 2017-05-22 | $28.10M 10-K · filed 2018-03-01 | |
| 2015-03-28 | $3.30M 10-Q/A · filed 2017-05-22 | $28.10M derived: sum of 2 quarters · filed 2017-05-22 | $28.10M 10-Q · filed 2015-04-29 | $28.10M derived: sum of 4 quarters · filed 2017-05-22 | |
| 2014-12-27 | $24.80M derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05 | $24.80M 10-Q · filed 2015-02-05 | $24.80M derived: sum of 3 quarters · filed 2017-05-22 | $24.80M derived: sum of 4 quarters · filed 2017-05-22 | |
| 2014-09-27 | $0.00 8-K · filed 2014-11-20 | $0.00 derived: sum of 2 quarters · filed 2017-05-22 | $0.00 derived: sum of 3 quarters · filed 2017-05-22 | $24.00M derived: sum of 4 quarters · filed 2017-05-22 | |
| 2014-06-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | $0.00 derived: sum of 2 quarters · filed 2017-05-22 | $24.00M derived: sum of 3 quarters · filed 2017-05-22 | $48.80M 10-K · filed 2017-05-22 | |
| 2014-03-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $24.00M derived: sum of 2 quarters · filed 2015-04-29 | $48.80M 10-Q · filed 2015-04-29 | $54.20M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-12-28 | $24.00M derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05 | $48.80M 10-Q · filed 2015-02-05 | $54.20M derived: sum of 3 quarters · filed 2016-02-25 | $54.20M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-09-28 | $24.80M 8-K · filed 2014-11-20 | $8.41M 10-Q · filed 2013-11-04 | $30.20M derived: sum of 2 quarters · filed 2016-02-25 | $30.20M derived: sum of 3 quarters · filed 2016-02-25 | |
| 2013-06-29 | $5.40M derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25 | $5.40M derived: sum of 2 quarters · filed 2016-02-25 | $6.00M 10-KT · filed 2016-02-25 | ||
| 2013-03-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $600.00K 10-Q · filed 2014-05-07 | |||
| 2012-12-29 | $600.00K 10-Q · filed 2014-02-06 | ||||
| 2012-06-30 | $5.10M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |